Should liposomal amphotericin B products be first line therapy for invasive aspergillosis in solid organ transplant recipients?
1998 ◽
Vol 3
(2)
◽
pp. 127-129
◽
2002 ◽
Vol 21
(1)
◽
pp. 170-171
2002 ◽
Vol 4
(4)
◽
pp. 195-200
◽
2009 ◽
Vol 9
◽
pp. S180-S191
◽
2006 ◽
Vol 81
(3)
◽
pp. 320-326
◽